This infographic offers an introduction to the real-world patient insights collected by our Therapy Watch Severe and Eosinophilic Asthma study. The data is collected from a panel of 400 physicians across 4 EU markets, Japan, and US.
Jump to a slide with the slide dots.
Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications.
Read moreJasdeep Mann, and Kankanala Thulasai, have produced a summary of the emerging treatment landscape for ulcerative colitis
Read moreLiving with CD covers 4EU+UK and Japan. Living with PsO covers the 4EU+UK. Living with IPF and PF-ILD covers the US, 4EU+UK and China.
Read moreRapport is our monthly newsletter where we share our latest expertise and experience.